Papillary Microcarcinomas of the Thyroid with Preoperatively Detectable Lymph Node Metastasis Show Significantly Higher Aggressive Characteristics on Immunohistochemical Examination

Oncology

Volumn 68, Issue 2-3, 2005, Pages 87-96

  Ito, Yasuhiro ^a   Uruno, Takashi ^a   Takamura, Yuuki ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Matsuzuka, Fumio ^a   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Apoptosis; Cell proliferation; KAI 1; Lymph node metastasis; Papillary microcarcinoma; Ultrasonography

Indexed keywords

CD82 ANTIGEN; CYCLIN D1; GENE PRODUCT; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P27; SINGLE STRANDED DNA; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KAI1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; ONCOPROTEIN; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; OCCULT CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE; CHEMISTRY; DISEASE FREE SURVIVAL; ECHOGRAPHY; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPH NODE; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD; APOPTOSIS; CARCINOMA, PAPILLARY; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE-FREE SURVIVAL; DNA, SINGLE-STRANDED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KANGAI-1 PROTEIN; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; THYROID NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 23844467810     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085701     Document Type: Article

References (32)

1. Yokozawa T, Miyauchi A, Kuma K, Sugawara M: Accurate and simple method of diagnosing thyroid nodules by the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid 1995;5:141-145.
2. Iida F, Sugenoya A, Muramatsu A: Clinical and pathologic properties of small differentiated carcinomas of the thyroid gland. World J Surg 1991;15:511-515.
3. Rodriguez JM, Parrilla MP, Sola J, Soria T, Tebar FJ, Aranda F: Papillary thyroid microcarcinoma: Clinical study and prognosis. Eur J Surg 1997;163:255-259.
4. Rassael H, Thompson LDR, Heffess CS: A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: A clinicopathological correlation of 90 cases. Eur Arch Otorhinolaryngol 1998;255:462-467.
5. Sugino K, Ito K Jr, Ozaki O, Mimura T, Iwasaki H, Ito K: Papillary microcarcinoma of the thyroid. J Endocrinol Invest 1998;21:445-448.
6. Hay ID, Grant CS, van Heerden JS, Goellner JR, Ebersold JR, Bergstralh EJ: Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery 1992;12:1139-1147.
7. Ito Y, Uruno R, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuuka F, Kuma S, Kuma K, Miyauchi A: An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-388.
8. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A: Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 2004;28:498-501.
9. Sasaki K, Murakami T, Kawasaki M: The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 1987;133:579-584.
10. Xiong Y, Connally T, Futcher B, Beach D: Human D-type cyclin. Cell 1991;65:691-699.
11. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27/Kip 1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
12. Chen PL, Scully P, Shew JY, Wang JY, Lee WH: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989;58:1193-1198.
13. Maeda M, Sugiyama T, Akai F, Jikihara I, Hayashi Y, Takagi H: Single strand DNA as an immunocytochemical marker for apoptotic change of ischemia in the gerbil hippocampus. Neurosci Lett 1998;240:69-72.
14. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature 1992;359:554-556.
15. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barret JC: KAI1, a metastatic suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
16. Ito Y, Yoshida H, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma K, Miyauchi A: KAI1 expression in thyroid neoplasms: Its linkage with clinicopathological features in papillary carcinoma. Pathol Res Pract 2003;199:79-83.
17. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Fallahi P, Baschieri L: Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 1995;5:25-29.
18. Kjellman P, Wallin G, Hoog A, Auer G, Larsson C, Zedenius J: MIB-1 index in thyroid tumors: A predictor of the clinical course in papillary thyroid carcinoma. Thyroid 2003;13:371-380.
19. Lazzereschi D, Sambuco L, Carnovale Scalzo C, Ranieri A, Mincione G, Nardi F, Colletta G: Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinoma. Int J Cancer 1998;76:806-811.
20. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV: Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 1998;11:169-174.
21. Khoo ML, Beasley NJ, Ezzat S, Freeman JL, Asa SL: Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab 2002;87:1814-1818.
22. Khoo ML, Ezzat S, Freeman JL, Asa SL: Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab 2002;87:1810-1813.
23. Khoo ML, Freeman JL, Witterick IJ, Irish JC, Rotstein LE, Gullane PJ, Asa SL: Underexpression of p27/kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 2002;128:253-257.
24. Holms R, Nesland JM: Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid. J Pathol 1994;172:267-272.
25. Ito Y, Kobayashi T, Takeda T, Wakasugi E, Tamaki Y, Umeshita K, Monden T, Monden M: Expression of the retinoblastoma gene product in clinical thyroid tissues: A reason for the slow growth of thyroid carcinoma. Oncol Rep 1996;3:57-62.
26. Hui AM, Li X, Makuuchi M, Takayama T, Kubota K: Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 1999;84:604-608.
27. Milde-Langosch K, Hagen M, Bamberger AM, Loning T: Expression and prognostic value of the cell-cycle regulatory proteins, Rb, P16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2 in ovarian cancer. Int J Gynecol Pathol 2003;22:168-174.
28. Haitel A, Wiener HG, Neudert B: Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 2001;58:477-481.
29. Korkolopoulou PA, Angelopoulou MK, Kontopidou FN: Retinoblastoma gene product and p21 (WAF1, CIP1) protein expression in non-Hodgkin's lymphomas: A multivariate survival analysis. Leuk Lymphoma 2001;40:647-658.
30. Omura K, Nagasato A, Kanehira E, Kinsen H, Amaya S, Kimura K, Kajita T, Nozaki Y, Mizukami Y, Nonomura A, Watanabe Y: Retinoblastoma protein and proliferating-cell nuclear antigen expression as predictors of recurrence in well-differentiated papillary thyroid carcinoma. J Clin Oncol 1997;15:3458-3463.
31. Ito Y, Yoshida H, Nakano K, Takamura T, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kakudo K, Kuma K, Miyauchi A: Bag-1 exprerssion in thyroid neoplasm: Its correlation with bcl-2 expression and carcinoma dedifferentiation. Anticancer Res 2003;23:569-576.
32. Moore D, Ohene-Fianko D, Garcia B, Chakrabarti S: Apoptosis in thyroid neoplasms: Relationship with p53 and bcl-2 expression. Histopathology 1998;32:35-42.